Corona Corporation
Corona Corporation (5909.T) Financial Performance & Income Statement Overview
View comprehensive annual and quarterly summaries for Corona Corporation (5909.T), featuring income statements, balance sheets, and cash flow data.
Corona Corporation (5909.T) Income Statement & Financial Overview
Review Corona Corporation 5909.T income statement with detailed quarterly and annual figures.
Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
---|---|---|---|---|
Revenue | $16.09B | $29.00B | $21.27B | $18.86B |
Cost of Revenue | $12.87B | $22.04B | $16.60B | $15.32B |
Gross Profit | $3.22B | $6.96B | $4.67B | $3.54B |
Gross Profit Ratio | $0.20 | $0.24 | $0.22 | $0.19 |
R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
SG&A Expenses | $4.21B | $4.66B | $4.31B | $3.87B |
Operating Expenses | $4.21B | $4.66B | $4.31B | $3.87B |
Total Costs & Expenses | $17.08B | $26.70B | $20.91B | $19.18B |
Interest Income | $53.00M | $0.00 | $45.00M | $46.00M |
Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
Depreciation & Amortization | $395.00M | $548.00M | $396.00M | $548.00M |
EBITDA | -$538.00M | $2.84B | $821.00M | $224.00M |
EBITDA Ratio | -$0.03 | $0.10 | $0.04 | $0.01 |
Operating Income | -$989.00M | $2.29B | $362.00M | -$323.00M |
Operating Income Ratio | -$0.06 | $0.08 | $0.02 | -$0.02 |
Other Income/Expenses (Net) | $54.00M | $140.00M | $65.00M | $98.00M |
Income Before Tax | -$935.00M | $2.43B | $427.00M | -$225.00M |
Income Before Tax Ratio | -$0.06 | $0.08 | $0.02 | -$0.01 |
Income Tax Expense | -$157.00M | $694.00M | $97.00M | $37.00M |
Net Income | -$779.00M | $1.74B | $330.00M | -$188.00M |
Net Income Ratio | -$0.05 | $0.06 | $0.02 | -$0.010 |
EPS | -$26.67 | $59.57 | $11.31 | -$6.44 |
Diluted EPS | -$26.67 | $59.57 | $11.31 | -$6.44 |
Weighted Avg Shares Outstanding | $29.21M | $29.21M | $29.18M | $29.18M |
Weighted Avg Shares Outstanding (Diluted) | $29.21M | $29.21M | $29.18M | $29.18M |
Over the last four quarters, Corona Corporation achieved steady financial progress, growing revenue from $18.86B in Q1 2024 to $16.09B in Q4 2024. Gross profit stayed firm with margins at 20% in Q4 2024 versus 19% in Q1 2024. Operating income totaled -$989.00M in Q4 2024, maintaining a -6% margin over recent quarters. Despite shifts in R&D and SG&A costs, EBITDA stayed strong at -$538.00M. Net income dropped to -$779.00M, with EPS at -$26.67. Disciplined expense strategies and efficient operations ensured sustained profitability and long-term financial stability.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan